Demand for scar treatment will increase through 2035, with topical treatments at 57.0% share of the treatment segment in 2025. Atrophic scars accounted for 48.9% share of the indication segment in 2025. The market was valued at USD 19.1 billion in 2025 and USD 43.5 billion by 2035.